CTTI will report on the progress and results of several key projects at the Society for Clinical Trials (SCT) annual meeting taking place on May 16 - 18, 2011, in Vancouver, Canada.
On Tuesday, May 17, team leads will present the results of a research project to improve safety reporting to IND investigators, including primary research findings, patient perspectives, and expert panel conclusions. A representative from FDA will discuss the implications of the new FDA premarketing safety reporting requirements in this context.
On Wednesday, May 18, there will be a CTTI panel session during which the results and recommendations of two projects, and an update on several ongoing projects, will be presented. A representative from FDA will participate on the panel to provide a regulatory perspective on CTTI findings and recommendations.
To view session abstracts, click here to access the program. (Tuesday, May 17: Session 21, and Wednesday, May 18: Session 27)